Anxiolytic-like effect of neuropeptide S in the rat defensive burying

Allen, 2006, Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease, Am J Physiol Lung Cell Mol Physiol, 291, 1005, 10.1152/ajplung.00174.2006 Badia-Elder, 2008, The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats, Alcohol Clin Exp Res, 32, 1, 10.1111/j.1530-0277.2008.00713.x Beck, 2005, Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats, Biochem Biophys Res Commun, 332, 859, 10.1016/j.bbrc.2005.05.029 Bhattacharya, 1997, Anxiogenic action of caffeine: an experimental study in rats, J Psychopharmacol, 11, 219, 10.1177/026988119701100304 Bystritsky, 2006, Treatment-resistant anxiety disorders, Mol Psychiatry, 11, 805, 10.1038/sj.mp.4001852 Charney, 1996, A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders, Crit Rev Neurobiol, 10, 419, 10.1615/CritRevNeurobiol.v10.i3-4.70 Craft, 1988, Conditioned defensive burying as a model for identifying anxiolytics, Pharmacol Biochem Behav, 30, 775, 10.1016/0091-3057(88)90098-6 Be Boer, 1990, Plasma catecholamine and corticosterone levels during active and passive shock-prod avoidance behavior in rats: effects of chlordiazepoxide, Physiol Behav, 47, 1089, 10.1016/0031-9384(90)90357-A De Boer, 2003, Defensive burying in rodents: ethology, neurobiology and psychopharmacology, Eur J Pharmacol, 463, 145, 10.1016/S0014-2999(03)01278-0 Fernández-Guasti, 2003, Orchidectomy sensitizes male rats to the action of diazepam on burying behavior latency: role of testosterone, Pharmacol Biochem Behav, 75, 473, 10.1016/S0091-3057(03)00142-4 File, 2004, Animal tests of anxiety, Curr Protoc Neurosci, 10.1002/0471142301.ns0803s26 George, 2001, Effects of nicotine pretreatments on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects, Biol Psychiatry, 49, 300, 10.1016/S0006-3223(00)00928-8 Gupte, 2004, Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach, Proc Natl Acad Sci USA, 101, 1508, 10.1073/pnas.0308250100 Jain, 2005, Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats, Neuropharmacology, 48, 627, 10.1016/j.neuropharm.2004.11.016 Jiménez-Velázquez, 2006, Influence of pharmacologically-induced experimental anxiety on nociception and antinociception in rats, Eur J Pharmacol, 547, 83, 10.1016/j.ejphar.2006.06.060 Kassel, 2000, Smoking, anxiety, and attention: support for the role of nicotine in attentionally mediated anxiolysis, J Abnorm Psychol, 109, 161, 10.1037/0021-843X.109.1.161 Koob, 2004, Neuropeptide S: a novel activating anxiolytic?, Neuron, 43, 441, 10.1016/j.neuron.2004.08.007 Leonard, 2008, Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders, Psychopharmacology (Berl), 197, 601, 10.1007/s00213-008-1080-4 Okamura, 2008, Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor, J Pharmacol Exp Ther, 325, 893, 10.1124/jpet.107.135103 Picazo, 1995, Antianxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test, Brain Res, 680, 135, 10.1016/0006-8993(95)00254-N Reinscheid, 2005, Pharmacological characterization of human and murine neuropeptide S receptor variants, J Pharmacol Exp Ther, 315, 1338, 10.1124/jpet.105.093427 Reinscheid, 2007, Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods, Peptides, 28, 830, 10.1016/j.peptides.2007.01.008 Rizzi, 2008, Neuropeptide S is a stimulatory anxiolytic agent: a behavioral study in mice, Br J Pharmacol, 154, 471, 10.1038/bjp.2008.96 Rodríguez-Manzo, 1999, Anxiolytic-like effect of ejaculation under various sexual behavior conditions in the male rat, Physiol Behav, 67, 651, 10.1016/S0031-9384(99)00119-5 Roth, 2006, Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation, J Biol Chem, 281, 20809, 10.1074/jbc.M601846200 Sah, 2003, The amygdaloid complex: anatomy and physiology, Physiol Rev, 83, 803, 10.1152/physrev.00002.2003 Smith, 2006, Neuropeptide S stimulates the hypothalamo–pituitary–adrenal axis and inhibits food intake, Endocrinology, 147, 3510, 10.1210/en.2005-1280 Treit, 1981, Conditioned defensive burying: a new paradigm for the study of anxiolytic agents, Pharmacol Biochem Behav, 15, 619, 10.1016/0091-3057(81)90219-7 Violle, 2006, Ethological comparison of the effects of a bovine alpha s1-casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety, Pharmacol Biochem Behav, 84, 517, 10.1016/j.pbb.2006.06.017 Vitale, 2006, Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats, Peptides, 27, 2193, 10.1016/j.peptides.2006.04.003 Wilson, 2004, Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females, Pharmacol Biochem Behav, 78, 445, 10.1016/j.pbb.2004.04.017 Xu, 2007, Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain, J Comp Neurol, 500, 84, 10.1002/cne.21159 Xu, 2004, Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects, Neuron, 43, 487, 10.1016/j.neuron.2004.08.005